2021 Biotechnology Research Review
Report Highlights:
Advancement in molecular biology is supporting the delivery of molecular and computational tools and software. Synthetic biology is another field of application that promotes the manufacturing of and/or modification of genetic material in living cells.
Unlike other industries, the biotech industry has witnessed high growth throughout the pandemic. The search for diagnostic treatment methods for COVID-19 has forced governments, the media and the general public alike to focus on science and medicine, strengthening the idea that biotech acquisitions and partnerships are solid investments. Companies operating in the cell line market are now investing large amounts, enabling the development of manufacturing units with advanced, state of the art resources and expanded facilities. At the same time, genetic sequencing technology is advancing at a great pace, especially across the healthcare sector in the diagnosis of various cancers and strains of Coronavirus.
In 2019 and 2020, the biotech industry saw double digit annual growth due to fundraising from venture capitals, partnerships, co-development and joint ventures. However, the sector does continuous challenging relating to marketing, funding for innovation and pricing pressures from government organizations. Development costs are also a challenge, and often the most critical for manufacturers. While a simple cholesterol drug may cost $5 per day (approximately $1,825 per annum), a biotech drug may cost around $20,000 or more a year.
In 2019, gene therapy and cell biology technologies were successfully developed, however, this came at a high cost. For example, Zolgensma, a viral vector-based gene therapy for the treatment of spinal muscular atrophy costs around $5 million. It is important for manufacturers to figure out how to balance the cost of innovation that proves most challenging. Getting the pricing right, and the costs involved with getting the products to market are also vital challenges. Innovation may take several years to move from a clinical trial phase to market launch, and investors may face disappointment and falling stock if expectations are not managed from the offset.
This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2021 on the following biotech markets -
- The global market for exosome diagnostics and therapeutics should grow from $97.8 million in 2021 to $512.6 million by 2026, at compound annual growth rate (CAGR) of 39.3% for the period of 2021-2026.
- The global market for bioinformatics should grow from $16.1 billion in 2020 to $24.1 billion by 2025 with a compound annual growth rate (CAGR) of 8.4% for the period of 2020-2025.
- The global market for cell and gene therapy should grow from $4.1 billion in 2021 to $17.4 billion by 2026 with a compound annual growth rate (CAGR) of 33.6% for the period of 2021-2026.
Advancement in molecular biology is supporting the delivery of molecular and computational tools and software. Synthetic biology is another field of application that promotes the manufacturing of and/or modification of genetic material in living cells.
Unlike other industries, the biotech industry has witnessed high growth throughout the pandemic. The search for diagnostic treatment methods for COVID-19 has forced governments, the media and the general public alike to focus on science and medicine, strengthening the idea that biotech acquisitions and partnerships are solid investments. Companies operating in the cell line market are now investing large amounts, enabling the development of manufacturing units with advanced, state of the art resources and expanded facilities. At the same time, genetic sequencing technology is advancing at a great pace, especially across the healthcare sector in the diagnosis of various cancers and strains of Coronavirus.
In 2019 and 2020, the biotech industry saw double digit annual growth due to fundraising from venture capitals, partnerships, co-development and joint ventures. However, the sector does continuous challenging relating to marketing, funding for innovation and pricing pressures from government organizations. Development costs are also a challenge, and often the most critical for manufacturers. While a simple cholesterol drug may cost $5 per day (approximately $1,825 per annum), a biotech drug may cost around $20,000 or more a year.
In 2019, gene therapy and cell biology technologies were successfully developed, however, this came at a high cost. For example, Zolgensma, a viral vector-based gene therapy for the treatment of spinal muscular atrophy costs around $5 million. It is important for manufacturers to figure out how to balance the cost of innovation that proves most challenging. Getting the pricing right, and the costs involved with getting the products to market are also vital challenges. Innovation may take several years to move from a clinical trial phase to market launch, and investors may face disappointment and falling stock if expectations are not managed from the offset.
This Biotechnology Research Review provides a sampling of the type of quantitative market information, analysis and guidance that has been aiding business decision making since BCC Research was founded in 1971. It includes highlights of reports published in 2021 on the following biotech markets -
- BIO149D Exosome Diagnostics and Therapeutics: Global Markets
- BIO051F Bioinformatics: Technologies and Global Markets
- BIO225A Global Cell and Gene Therapy Market
- BIO126D Next-generation Sequencing: Emerging Clinical Applications and Global Markets
- BIO083D Life Science Tools and Reagents: Global Markets
- BIO045H Global DNA Sequencing: Research, Applied and Clinical Markets
- BIO212A mRNA: Therapeutics and Global Markets
- BIO158B Cancer Stem Cells: Technologies and Global Markets
- BIO150D Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
- BIO135D Induced Pluripotent Stem Cells: Global Markets
- BIO141C Global Markets for Research Antibodies
- BIO211A Cell Therapy Biomanufacturing: Global Markets
CHAPTER 1 FOREWORD
Foreword
CHAPTER 2 EXOSOME DIAGNOSTICS AND THERAPEUTICS: GLOBAL MARKETS (BIO149D)
Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Intended Audience
Related BCC Research Reports
Summary and Highlights
Market Overview
Exosome Definition and Nomenclature
Exosome Components
Exosome and COVID-19 Treatment
Exosome Diagnostic Market
Exosome Therapeutic Market
Market Breakdown by End User
Market Breakdown by Region
Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Pipeline Analysis
CHAPTER 3 BIOINFORMATICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO051F)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Trends
Market Breakdown
Global Market for Bioinformatics by Sequencing Services and Platforms
Global Market for Bioinformatics by Solution
Global Market for Bioinformatics by End User
Global Market for Bioinformatics by Region
Bioinformatics Applications in Pharmaceutical R&D
Drug Discovery and Development Process
Clinical Research: Drug Development
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
CHAPTER 4 GLOBAL CELL AND GENE THERAPY MARKET (BIO225A)
Introduction
Study Goals and Objectives
Scope of This Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Highlights of the Market for Cell and Gene Therapy
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Breakdown by Product
Market Breakdown by Application
Market Breakdown by Region
Pipeline Analysis
Drugs Pending Approval
Competitive Landscape: Overview
Market Share Analysis
Strategic Acquisitions and Collaborations
CHAPTER 5 NEXT-GENERATION SEQUENCING: EMERGING CLINICAL APPLICATIONS AND GLOBAL MARKETS (BIO126D)
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Next-generation Sequencing and Markets
Clinical NGS Testing Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Sequencing Technologies
History of DNA Sequencing
Clinical NGS Markets
Market Dynamics
Clinical NGS Market by Disease Category
Clinical NGS Market by Complexity
Clinical NGS Market by Test Purpose
Geographical Markets
CHAPTER 6 LIFE SCIENCE TOOLS AND REAGENTS: GLOBAL MARKETS (BIO083D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Market Drivers
Market Restraints and Challenges
Market Opportunities
Global Market for Life Science Tools and Reagents, by End-User Application
Global Market for Life Science Tools and Diagnostics, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 GLOBAL DNA SEQUENCING: RESEARCH, APPLIED AND CLINICAL MARKETS (BIO045H)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Overview
Sequencing Growth Driving Forces
Research and Applied Applications
Clinical Applications
Market for DNA Sequencing
Market Breakdown by Major Segment
Geographical Markets
CHAPTER 8 MRNA: THERAPEUTICS AND GLOBAL MARKETS (BIO212A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Market Situation for RNA Therapeutics
Well-Developed Markets
Developing Markets
Underdeveloped Markets
mRNA Vaccines
Clinical Need for mRNA Vaccines
mRNA Vaccines and Types by Application
Marketed/Commercial mRNA Vaccines
mRNA Vaccines: New Developments
mRNA Vaccines and Future Pandemics
mRNA Drugs and Therapies
Clinical Need for mRNA Therapeutics Beyond Vaccines
mRNA as Gene and Protein Replacement Therapy
mRNA-Enhanced Cell Therapies
mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
mRNA Therapeutics and New Developments
Market Size and Growth Analysis by Product Segment
Market Size and Growth Analysis by Therapeutic Application
Market Size and Growth Analysis by Disease Type
SWOT Analysis of the Market for mRNA Therapeutics
CHAPTER 9 CANCER STEM CELLS: TECHNOLOGIES AND GLOBAL MARKETS (BIO158B)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources & Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Drivers
Restraints
Opportunity
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
CHAPTER 10 GLOBAL MARKETS FOR RESEARCH ANTIBODIES (BIO141C)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Global Market for Research Antibodies by Product
Global Market for Research Antibodies by Clonality
Global Market for Research Antibodies by Major Reactivities
Global Market for Research Antibodies by Host Species
Global Market for Research Antibodies by End User
Global Market for Research Antibodies by Region
Global Company Market Ranking Analysis
CHAPTER 11 LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS (BIO150D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Industry Overview
Forces Driving Growth
Key Trends
Liquid Biopsy Initiatives
Global Market for Liquid Biopsy by Clinical Category
Global Market for Non-invasive Prenatal Testing
Global Market for Liquid Biopsy for Cancer Diagnostics
Global Market for Liquid Biopsy for Transplant Diagnostics
Global Market for Liquid Biopsy by Purpose of Analysis
Global Market for Liquid Biopsy by Biomarker Type
Global Market for Liquid Biopsy by Analysis Platform
Global Market for Liquid Biopsy by Geographic Region
CHAPTER 12 INDUCED PLURIPOTENT STEM CELLS: GLOBAL MARKETS (BIO135D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Key Drivers for Market Growth
Technology Overview
Induced Pluripotent Stem Cell Generation
Induced Pluripotent Stem Cell Differentiation
Current Challenges to iPSC Applications
iPSCs Bank
Impact of COVID-19 on iPSCs
Pluripotent Stem Cells as a Study Model for COVID-19
Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
Market Overview
Market Breakdown by Region
Market Breakdown by Reprogramming Method
Market Breakdown by Application
Market Breakdown by Product
Induced Pluripotent Stem Cell-Derived Tissue Cell Market
Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
Market for Induced Pluripotent Stem Cells by Product Function
Research Market Compared with the Clinical Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Induced Pluripotent Stem Cell Contract Service Types
Market Shares and Projections
CHAPTER 13 CELL THERAPY BIOMANUFACTURING: GLOBAL MARKETS (BIO211A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Breakdown by Application
Market Breakdown by Region
Market Trends & Challenges
Drivers
Restraints
Opportunity
Challenges
Foreword
CHAPTER 2 EXOSOME DIAGNOSTICS AND THERAPEUTICS: GLOBAL MARKETS (BIO149D)
Introduction
Study Goals and Objectives
Scope of Report
Information Sources
Intended Audience
Related BCC Research Reports
Summary and Highlights
Market Overview
Exosome Definition and Nomenclature
Exosome Components
Exosome and COVID-19 Treatment
Exosome Diagnostic Market
Exosome Therapeutic Market
Market Breakdown by End User
Market Breakdown by Region
Patent Analysis
U.S. Patent Analysis
European Patent Analysis
Pipeline Analysis
CHAPTER 3 BIOINFORMATICS: TECHNOLOGIES AND GLOBAL MARKETS (BIO051F)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Research Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Trends
Market Breakdown
Global Market for Bioinformatics by Sequencing Services and Platforms
Global Market for Bioinformatics by Solution
Global Market for Bioinformatics by End User
Global Market for Bioinformatics by Region
Bioinformatics Applications in Pharmaceutical R&D
Drug Discovery and Development Process
Clinical Research: Drug Development
Post-Launch Ongoing Studies and Phase IV Clinical Trials
Recent Pharmaceutical and Bioinformatics Alliances and Partnerships
Conclusions
CHAPTER 4 GLOBAL CELL AND GENE THERAPY MARKET (BIO225A)
Introduction
Study Goals and Objectives
Scope of This Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Highlights of the Market for Cell and Gene Therapy
Market Dynamics
Market Drivers
Market Restraints
Market Opportunities
Market Breakdown by Product
Market Breakdown by Application
Market Breakdown by Region
Pipeline Analysis
Drugs Pending Approval
Competitive Landscape: Overview
Market Share Analysis
Strategic Acquisitions and Collaborations
CHAPTER 5 NEXT-GENERATION SEQUENCING: EMERGING CLINICAL APPLICATIONS AND GLOBAL MARKETS (BIO126D)
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Scope of Report
Methodology
Information Sources
Geographical Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Next-generation Sequencing and Markets
Clinical NGS Testing Market
Growth Drivers of Clinical NGS
Key Trends
Industry
Sequencing Technologies
History of DNA Sequencing
Clinical NGS Markets
Market Dynamics
Clinical NGS Market by Disease Category
Clinical NGS Market by Complexity
Clinical NGS Market by Test Purpose
Geographical Markets
CHAPTER 6 LIFE SCIENCE TOOLS AND REAGENTS: GLOBAL MARKETS (BIO083D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Market Drivers
Market Restraints and Challenges
Market Opportunities
Global Market for Life Science Tools and Reagents, by End-User Application
Global Market for Life Science Tools and Diagnostics, by Region
North America
Europe
Asia-Pacific
Rest of the World
CHAPTER 7 GLOBAL DNA SEQUENCING: RESEARCH, APPLIED AND CLINICAL MARKETS (BIO045H)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Overview
Sequencing Growth Driving Forces
Research and Applied Applications
Clinical Applications
Market for DNA Sequencing
Market Breakdown by Major Segment
Geographical Markets
CHAPTER 8 MRNA: THERAPEUTICS AND GLOBAL MARKETS (BIO212A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources and Methodology
Intended Audience
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Summary and Highlights
Market Situation for RNA Therapeutics
Well-Developed Markets
Developing Markets
Underdeveloped Markets
mRNA Vaccines
Clinical Need for mRNA Vaccines
mRNA Vaccines and Types by Application
Marketed/Commercial mRNA Vaccines
mRNA Vaccines: New Developments
mRNA Vaccines and Future Pandemics
mRNA Drugs and Therapies
Clinical Need for mRNA Therapeutics Beyond Vaccines
mRNA as Gene and Protein Replacement Therapy
mRNA-Enhanced Cell Therapies
mRNA-Enhanced Immunotherapies (Monoclonal Antibody)
mRNA Drugs for Protein Therapy Targeting Metabolic and Rare Diseases
mRNA Therapeutics and New Developments
Market Size and Growth Analysis by Product Segment
Market Size and Growth Analysis by Therapeutic Application
Market Size and Growth Analysis by Disease Type
SWOT Analysis of the Market for mRNA Therapeutics
CHAPTER 9 CANCER STEM CELLS: TECHNOLOGIES AND GLOBAL MARKETS (BIO158B)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources & Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Market Dynamics
Drivers
Restraints
Opportunity
Market Breakdown by Region
North America
Europe
Asia-Pacific
Rest of the World (RoW)
CHAPTER 10 GLOBAL MARKETS FOR RESEARCH ANTIBODIES (BIO141C)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Trends in the Market for Research Antibodies
Purchasing Factors Analysis
Third-Party Quality Evaluation Systems
Research Grants
Global Market for Research Antibodies by Product
Global Market for Research Antibodies by Clonality
Global Market for Research Antibodies by Major Reactivities
Global Market for Research Antibodies by Host Species
Global Market for Research Antibodies by End User
Global Market for Research Antibodies by Region
Global Company Market Ranking Analysis
CHAPTER 11 LIQUID BIOPSY RESEARCH TOOLS, SERVICES AND DIAGNOSTICS: GLOBAL MARKETS (BIO150D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst’s Credentials
Related BCC Research Reports
Summary and Highlights
Industry Overview
Forces Driving Growth
Key Trends
Liquid Biopsy Initiatives
Global Market for Liquid Biopsy by Clinical Category
Global Market for Non-invasive Prenatal Testing
Global Market for Liquid Biopsy for Cancer Diagnostics
Global Market for Liquid Biopsy for Transplant Diagnostics
Global Market for Liquid Biopsy by Purpose of Analysis
Global Market for Liquid Biopsy by Biomarker Type
Global Market for Liquid Biopsy by Analysis Platform
Global Market for Liquid Biopsy by Geographic Region
CHAPTER 12 INDUCED PLURIPOTENT STEM CELLS: GLOBAL MARKETS (BIO135D)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Key Drivers for Market Growth
Technology Overview
Induced Pluripotent Stem Cell Generation
Induced Pluripotent Stem Cell Differentiation
Current Challenges to iPSC Applications
iPSCs Bank
Impact of COVID-19 on iPSCs
Pluripotent Stem Cells as a Study Model for COVID-19
Scientists Use Stem Cells to Uncover COVID-19 Effects on the Heart
Market Overview
Market Breakdown by Region
Market Breakdown by Reprogramming Method
Market Breakdown by Application
Market Breakdown by Product
Induced Pluripotent Stem Cell-Derived Tissue Cell Market
Induced Pluripotent Stem Cells and Their Derivative Cell Market by Species
Market for Induced Pluripotent Stem Cells Derived Cell Market by Application
Market for Induced Pluripotent Stem Cells by Product Function
Research Market Compared with the Clinical Market
Major Suppliers and Manufacturers of Induced Pluripotent Stem Cell Products
Induced Pluripotent Stem Cell Contract Service Types
Market Shares and Projections
CHAPTER 13 CELL THERAPY BIOMANUFACTURING: GLOBAL MARKETS (BIO211A)
Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Related BCC Research Reports
Summary and Highlights
Market Breakdown by Application
Market Breakdown by Region
Market Trends & Challenges
Drivers
Restraints
Opportunity
Challenges
LIST OF TABLES
Table 1: Global Market for Exosome Diagnostics and Therapeutics, by Application, Through 2026
Table 2: Nomenclature of Exosome Particles
Table 3: Publication Trend about Exosome, 2010-2020
Table 4: Examples of Exosomal Proteins for Clinical Diagnostic Applications
Table 5: Examples of Studies Using Extracellular Vesicles as Drug Delivery Vehicles
Table 6: Examples of Engineering Exosome for Cargo Delivery
Table 7: Global Market for Exosome Therapeutics and Diagnostics, by End User, Through 2026
Table 8: Global Market for Exosome Diagnostics and Therapeutics, by Region, Through 2026
Table 9: U.S. Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 10: European Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 11: Clinical Trials on Various Exosome Molecules
Table 12: Global Market for Bioinformatics, by Application, Through 2025
Table 13: Global Market for Sequencing Services and Platforms, Through 2025
Table 14: Global Market for Bioinformatics, by Solution, Through 2025
Table 15: Global Market for Bioinformatics, by End User, Through 2025
Table 16: Global Market for Bioinformatics, by Region, Through 2025
Table 17: North American Market for Bioinformatics, by Solution, Through 2025
Table 18: North American Market for Sequencing Services and Platforms, Through 2025
Table 19: North American Market for Bioinformatics, by Application, Through 2025
Table 20: North American Market for Bioinformatics, by End User, Through 2025
Table 21: North American Market for Bioinformatics, by Country, Through 2025
Table 22: European Market for Bioinformatics, by Solution, Through 2025
Table 23: European Market for Sequencing Services and Platforms, Through 2025
Table 24: European Market for Bioinformatics, by Application, Through 2025
Table 25: European Market for Bioinformatics, by End User, Through 2025
Table 26: European Market for Bioinformatics, by Country, Through 2025
Table 27: Asia-Pacific Market for Bioinformatics, by Solution, Through 2025
Table 28: Asia-Pacific Market for Sequencing Services and Platforms, Through 2025
Table 29: Asia-Pacific Market for Bioinformatics, by Application, Through 2025
Table 30: Asia-Pacific Market for Bioinformatics, by End User, Through 2025
Table 31: Asia-Pacific Market for Bioinformatics, by Country, Through 2025
Table 32: Rest of the World Market for Bioinformatics, by Solution, Through 2025
Table 33: Rest of the World Market for Sequencing Services and Platforms, Through 2025
Table 34: Rest of the World Market for Bioinformatics, by Application, Through 2025
Table 35: Rest of the World Market for Bioinformatics, by End User, Through 2025
Table 36: Rest of the World Market for Bioinformatics, by Country, Through 2025
Table 37: Bioinformatics Databases
Table 38: Leading Drug Target Databases
Table 39: Application of Cloud-Based Services in Healthcare
Table 40: Leading LIMS Providers
Table 41: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 42: Leading EHR Providers, 2018
Table 43: Medical Applications for Healthcare Professionals
Table 44: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2020
Table 45: Global Market for Cell and Gene Therapy, by Therapy Type, Through 2026
Table 46: Total Number of New Cases and Deaths Due to Various Cancers Globally, 2020
Table 47: Comparison of Accelerated Approvals for Various Drugs
Table 48: Global Market for Cell and Gene Therapy, by Product, Through 2026
Table 49: Global Market for CGTs, by Application, Through 2026
Table 50: Global Market for Cell and Gene Therapy, by Region, Through 2026
Table 51: Total Number of Clinical Trials, by Indication, 2020
Table 52: Key CGT Drug Candidates in Phase I Trials
Table 53: Key CGT Drug Candidates in Phase II Trials
Table 54: Key CGT Drug Candidates in Phase III Trials
Table 55: CGT Drug Awaiting Approvals
Table 56: Novartis Acquisitions and Collaborations Portfolio, 2018-2021
Table 57: Gilead Acquisitions and Collaborations Portfolio
Table 58: Global Market for Clinical Next-Generation Sequencing, by Disease Class, Through 2025
Table 59: Scope of the Report
Table 60: Global Market for Clinical NGS Testing, by Disease Type, Through 2025
Table 61: Forces Influencing Growth in the Clinical NGS Testing Market
Table 62: Key Trends in the Clinical NGS Testing Market
Table 63: Clinical NGS Industry Subsectors
Table 64: DNA Sequencing Historical Timeline
Table 65: Sequencing Technology Development, 1990-2020
Table 66: Cost of Sequencing a Single Human Genome, 2001-2021
Table 67: Key Forces Driving Growth in Clinical NGS and Their Implications
Table 68: Global Market for Clinical Sequencing, by Disease Category, Through 2025
Table 69: Global Market for Clinical NGS in Oncology, by Indication, Through 2025
Table 70: Global Market for Clinical NGS, by Test Complexity, Through 2025
Table 71: Global Market for Clinical NGS, by Purpose of Test, Through 2025
Table 72: Global Market for Clinical NGS, by Region, Through 2025
Table 73: Global Market for Life Science Tools and Diagnostics, by Product Type, Through 2025
Table 74: Distribution of COVID-19 Clinical Symptoms
Table 75: Total Number of COVID-19 Confirmed Cases and Deaths Globally, by Region, Through Nov. 10, 2020
Table 76: Global Market for Life Science Tools and Reagents, by End-User, Through 2025
Table 77: Global Market for Life Science Tools and Diagnostics, by Region, Through 2025
Table 78: North American Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 79: European Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 80: Asia-Pacific Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 81: Global Market for DNA Sequencing, by Major Segment, Through 2026
Table 82: Key Forces Driving Growth in Market for DNA Sequencing and Their Implications
Table 83: Number of Sequencing Projects in GOLD Database, 2018-2020
Table 84: Main Sequencing Applications
Table 85: Genetic Testing Scope
Table 86: Key Applications for Sequencing-Based Diagnostics
Table 87: Global Market for DNA Sequencing, by Major Segment, Through 2026
Table 88: Global Market for Sequencing Services, by End User, Through 2026
Table 89: Global Market for Applied Sequencing Services, by Application, Through 2026
Table 90: Global Market for Clinical Diagnostic Sequencing, by Disease Category, Through 2026
Table 91: Global Market for Sample Preparation, by Product Type, Through 2026
Table 92: Global Market for Sequencing Instruments and Consumables, by Product Type, Through 2026
Table 93: Global Market for Sequencing Instruments and Consumables, by Product Generation, Through 2026
Table 94: Global Market for DNA Sequencing, by Region, Through 2026
Table 95: Global Market for mRNA Therapeutics, by Country/Region, Through 2026
Table 96: Marketed/Commercial mRNA Vaccines, by Company
Table 97: mRNA Drugs for Protein Therapy, Metabolic and Rare Diseases, by Company
Table 98: Global Market for mRNA Therapeutics, by Product Segment, Through 2026
Table 99: Global Market Shares of mRNA Therapeutics, by Therapeutic Application, 2026
Table 100: Global Market for mRNA Therapeutics, by Disease Type, Through 2026
Table 101: SWOT Analysis of the Market for mRNA Therapeutics
Table 102: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 103: Global Market for Cancer Stem Cells, by Region, Through 2026
Table 104: North American Market for Cancer Stem Cells, by Country, Through 2026
Table 105: North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 106: European Market for Cancer Stem Cells, by Country, Through 2026
Table 107: European Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 108: Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
Table 109: Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 110: RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
Table 111: RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 112: Global Market for Research Antibodies, by Application, Through 2025
Table 113: Global Market for Research Antibodies, by Product, Through 2025
Table 114: Global Market for Research Antibodies, by Clonality, Through 2025
Table 115: Global Market for Research Antibodies, by Major Reactivities, Through 2025
Table 116: Global Market for Research Antibodies, by Host Species, Through 2025
Table 117: Global Market for Research Antibodies, by End User, Through 2025
Table 118: Global Market for Research Antibodies, by Region, Through 2025
Table 119: Global Market for Liquid Biopsy, by Disease Class, Through 2025
Table 120: Forces Driving Growth in the Market for Liquid Biopsy
Table 121: Key Trends in the Market for Liquid Biopsy
Table 122: Liquid Biopsy-Related Research and Development Initiatives and Programs
Table 123: Global Market for Liquid Biopsy, by Clinical Category, Through 2025
Table 124: Global Market for NIPT, by Purpose of Analysis, Through 2025
Table 125: Global Market for NIPT, by Risk Type, Through 2025
Table 126: Global Market for NIPT Diagnostics, by Biomarker Class, Through 2025
Table 127: Global Market for NIPT, by Analysis Method, Through 2025
Table 128: Global Market for Liquid Biopsy for Cancer Diagnostics, by Cancer Site, Through 2025
Table 129: Global Liquid Biopsy Cancer Market, by Purpose of Analysis, Through 2025
Table 130: Global Market for Liquid Biopsy in Cancer Applications, by Biomarker Class, Through 2025
Table 131: Global Market for Liquid Biopsy in Cancer Applications, by Analysis Method, Through 2025
Table 132: Global Market for Liquid Biopsy in Transplant Applications, by Organ Type, Through 2025
Table 133: Transplant Procedures Performed in the U.S., by Organ, 2018-2020
Table 134: Global Market for Liquid Biopsy in Transplant Applications, by Purpose of Analysis, Through 2025
Table 135: Global Market for Liquid Biopsy in Transplant Applications, by Biomarker Class, Through 2025
Table 136: Global Market for Liquid Biopsy in Transplant Applications, by Analysis Method, Through 2025
Table 137: Global Market for Liquid Biopsy, by Purpose of Analysis, Through 2025
Table 138: Global Market for Liquid Biopsy, by Biomarker Type, Through 2025
Table 139: FDA-Approved or CE-Marked Tests with Epigenetic Component
Table 140: Global Market for Liquid Biopsy, by Analysis Platform, Through 2025
Table 141: Global Market for Liquid Biopsy, by Region, Through 2025
Table 142: Global Market for Liquid Biopsy in Cancer Applications, by Region, Through 2025
Table 143: Global Market for Liquid Biopsy for NIPT, by Region, Through 2025
Table 144: Global Market for Liquid Biopsy in Transplant Applications, by Region, Through 2025
Table 145: Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
Table 146: iPSCs Banks Worldwide, 2019
Table 147: Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
Table 148: U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2026
Table 149: European Market for Induced Pluripotent Stem Cells, by Country, Through 2026
Table 150: Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2026
Table 151: Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2026
Table 152: Global Market for the Generation of Induced Pluripotent Stem Cells, by Method, Through 2026
Table 153: Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 154: U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 155: European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 156: Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 157: Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 158: Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2026
Table 159: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Species, Through 2026
Table 160: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2026
Table 161: Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
Table 162: Global Market for Induced Pluripotent Stem Cells in Research and Clinical Uses, Through 2026
Table 163: Major Commercial Suppliers of Induced Pluripotent Stem Cells Products, by Country
Table 164: Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
Table 165: Major Companies Providing iPSC Contract Services, by State/Country
Table 166: Global Market for Induced Pluripotent Stem Cell Contract Services, by Country/Region, Through 2026
Table 167: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
Table 168: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
Table 1: Global Market for Exosome Diagnostics and Therapeutics, by Application, Through 2026
Table 2: Nomenclature of Exosome Particles
Table 3: Publication Trend about Exosome, 2010-2020
Table 4: Examples of Exosomal Proteins for Clinical Diagnostic Applications
Table 5: Examples of Studies Using Extracellular Vesicles as Drug Delivery Vehicles
Table 6: Examples of Engineering Exosome for Cargo Delivery
Table 7: Global Market for Exosome Therapeutics and Diagnostics, by End User, Through 2026
Table 8: Global Market for Exosome Diagnostics and Therapeutics, by Region, Through 2026
Table 9: U.S. Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 10: European Patents on Exosome Diagnostics and Therapeutics, January 2015–September 2021
Table 11: Clinical Trials on Various Exosome Molecules
Table 12: Global Market for Bioinformatics, by Application, Through 2025
Table 13: Global Market for Sequencing Services and Platforms, Through 2025
Table 14: Global Market for Bioinformatics, by Solution, Through 2025
Table 15: Global Market for Bioinformatics, by End User, Through 2025
Table 16: Global Market for Bioinformatics, by Region, Through 2025
Table 17: North American Market for Bioinformatics, by Solution, Through 2025
Table 18: North American Market for Sequencing Services and Platforms, Through 2025
Table 19: North American Market for Bioinformatics, by Application, Through 2025
Table 20: North American Market for Bioinformatics, by End User, Through 2025
Table 21: North American Market for Bioinformatics, by Country, Through 2025
Table 22: European Market for Bioinformatics, by Solution, Through 2025
Table 23: European Market for Sequencing Services and Platforms, Through 2025
Table 24: European Market for Bioinformatics, by Application, Through 2025
Table 25: European Market for Bioinformatics, by End User, Through 2025
Table 26: European Market for Bioinformatics, by Country, Through 2025
Table 27: Asia-Pacific Market for Bioinformatics, by Solution, Through 2025
Table 28: Asia-Pacific Market for Sequencing Services and Platforms, Through 2025
Table 29: Asia-Pacific Market for Bioinformatics, by Application, Through 2025
Table 30: Asia-Pacific Market for Bioinformatics, by End User, Through 2025
Table 31: Asia-Pacific Market for Bioinformatics, by Country, Through 2025
Table 32: Rest of the World Market for Bioinformatics, by Solution, Through 2025
Table 33: Rest of the World Market for Sequencing Services and Platforms, Through 2025
Table 34: Rest of the World Market for Bioinformatics, by Application, Through 2025
Table 35: Rest of the World Market for Bioinformatics, by End User, Through 2025
Table 36: Rest of the World Market for Bioinformatics, by Country, Through 2025
Table 37: Bioinformatics Databases
Table 38: Leading Drug Target Databases
Table 39: Application of Cloud-Based Services in Healthcare
Table 40: Leading LIMS Providers
Table 41: Leading Absorption, Distribution, Metabolism, Excretion and Toxicity Prediction Tools
Table 42: Leading EHR Providers, 2018
Table 43: Medical Applications for Healthcare Professionals
Table 44: Pharmaceutical and Bioinformatic Partnerships and Alliances, 2015-2020
Table 45: Global Market for Cell and Gene Therapy, by Therapy Type, Through 2026
Table 46: Total Number of New Cases and Deaths Due to Various Cancers Globally, 2020
Table 47: Comparison of Accelerated Approvals for Various Drugs
Table 48: Global Market for Cell and Gene Therapy, by Product, Through 2026
Table 49: Global Market for CGTs, by Application, Through 2026
Table 50: Global Market for Cell and Gene Therapy, by Region, Through 2026
Table 51: Total Number of Clinical Trials, by Indication, 2020
Table 52: Key CGT Drug Candidates in Phase I Trials
Table 53: Key CGT Drug Candidates in Phase II Trials
Table 54: Key CGT Drug Candidates in Phase III Trials
Table 55: CGT Drug Awaiting Approvals
Table 56: Novartis Acquisitions and Collaborations Portfolio, 2018-2021
Table 57: Gilead Acquisitions and Collaborations Portfolio
Table 58: Global Market for Clinical Next-Generation Sequencing, by Disease Class, Through 2025
Table 59: Scope of the Report
Table 60: Global Market for Clinical NGS Testing, by Disease Type, Through 2025
Table 61: Forces Influencing Growth in the Clinical NGS Testing Market
Table 62: Key Trends in the Clinical NGS Testing Market
Table 63: Clinical NGS Industry Subsectors
Table 64: DNA Sequencing Historical Timeline
Table 65: Sequencing Technology Development, 1990-2020
Table 66: Cost of Sequencing a Single Human Genome, 2001-2021
Table 67: Key Forces Driving Growth in Clinical NGS and Their Implications
Table 68: Global Market for Clinical Sequencing, by Disease Category, Through 2025
Table 69: Global Market for Clinical NGS in Oncology, by Indication, Through 2025
Table 70: Global Market for Clinical NGS, by Test Complexity, Through 2025
Table 71: Global Market for Clinical NGS, by Purpose of Test, Through 2025
Table 72: Global Market for Clinical NGS, by Region, Through 2025
Table 73: Global Market for Life Science Tools and Diagnostics, by Product Type, Through 2025
Table 74: Distribution of COVID-19 Clinical Symptoms
Table 75: Total Number of COVID-19 Confirmed Cases and Deaths Globally, by Region, Through Nov. 10, 2020
Table 76: Global Market for Life Science Tools and Reagents, by End-User, Through 2025
Table 77: Global Market for Life Science Tools and Diagnostics, by Region, Through 2025
Table 78: North American Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 79: European Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 80: Asia-Pacific Market for Life Science Tools and Diagnostics, by Country, Through 2025
Table 81: Global Market for DNA Sequencing, by Major Segment, Through 2026
Table 82: Key Forces Driving Growth in Market for DNA Sequencing and Their Implications
Table 83: Number of Sequencing Projects in GOLD Database, 2018-2020
Table 84: Main Sequencing Applications
Table 85: Genetic Testing Scope
Table 86: Key Applications for Sequencing-Based Diagnostics
Table 87: Global Market for DNA Sequencing, by Major Segment, Through 2026
Table 88: Global Market for Sequencing Services, by End User, Through 2026
Table 89: Global Market for Applied Sequencing Services, by Application, Through 2026
Table 90: Global Market for Clinical Diagnostic Sequencing, by Disease Category, Through 2026
Table 91: Global Market for Sample Preparation, by Product Type, Through 2026
Table 92: Global Market for Sequencing Instruments and Consumables, by Product Type, Through 2026
Table 93: Global Market for Sequencing Instruments and Consumables, by Product Generation, Through 2026
Table 94: Global Market for DNA Sequencing, by Region, Through 2026
Table 95: Global Market for mRNA Therapeutics, by Country/Region, Through 2026
Table 96: Marketed/Commercial mRNA Vaccines, by Company
Table 97: mRNA Drugs for Protein Therapy, Metabolic and Rare Diseases, by Company
Table 98: Global Market for mRNA Therapeutics, by Product Segment, Through 2026
Table 99: Global Market Shares of mRNA Therapeutics, by Therapeutic Application, 2026
Table 100: Global Market for mRNA Therapeutics, by Disease Type, Through 2026
Table 101: SWOT Analysis of the Market for mRNA Therapeutics
Table 102: Global Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 103: Global Market for Cancer Stem Cells, by Region, Through 2026
Table 104: North American Market for Cancer Stem Cells, by Country, Through 2026
Table 105: North American Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 106: European Market for Cancer Stem Cells, by Country, Through 2026
Table 107: European Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 108: Asia-Pacific Market for Cancer Stem Cells, by Country, Through 2026
Table 109: Asia-Pacific Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 110: RoW Market for Cancer Stem Cells, by Country/Region, Through 2026
Table 111: RoW Market for Cancer Stem Cells, by Cancer Type, Through 2026
Table 112: Global Market for Research Antibodies, by Application, Through 2025
Table 113: Global Market for Research Antibodies, by Product, Through 2025
Table 114: Global Market for Research Antibodies, by Clonality, Through 2025
Table 115: Global Market for Research Antibodies, by Major Reactivities, Through 2025
Table 116: Global Market for Research Antibodies, by Host Species, Through 2025
Table 117: Global Market for Research Antibodies, by End User, Through 2025
Table 118: Global Market for Research Antibodies, by Region, Through 2025
Table 119: Global Market for Liquid Biopsy, by Disease Class, Through 2025
Table 120: Forces Driving Growth in the Market for Liquid Biopsy
Table 121: Key Trends in the Market for Liquid Biopsy
Table 122: Liquid Biopsy-Related Research and Development Initiatives and Programs
Table 123: Global Market for Liquid Biopsy, by Clinical Category, Through 2025
Table 124: Global Market for NIPT, by Purpose of Analysis, Through 2025
Table 125: Global Market for NIPT, by Risk Type, Through 2025
Table 126: Global Market for NIPT Diagnostics, by Biomarker Class, Through 2025
Table 127: Global Market for NIPT, by Analysis Method, Through 2025
Table 128: Global Market for Liquid Biopsy for Cancer Diagnostics, by Cancer Site, Through 2025
Table 129: Global Liquid Biopsy Cancer Market, by Purpose of Analysis, Through 2025
Table 130: Global Market for Liquid Biopsy in Cancer Applications, by Biomarker Class, Through 2025
Table 131: Global Market for Liquid Biopsy in Cancer Applications, by Analysis Method, Through 2025
Table 132: Global Market for Liquid Biopsy in Transplant Applications, by Organ Type, Through 2025
Table 133: Transplant Procedures Performed in the U.S., by Organ, 2018-2020
Table 134: Global Market for Liquid Biopsy in Transplant Applications, by Purpose of Analysis, Through 2025
Table 135: Global Market for Liquid Biopsy in Transplant Applications, by Biomarker Class, Through 2025
Table 136: Global Market for Liquid Biopsy in Transplant Applications, by Analysis Method, Through 2025
Table 137: Global Market for Liquid Biopsy, by Purpose of Analysis, Through 2025
Table 138: Global Market for Liquid Biopsy, by Biomarker Type, Through 2025
Table 139: FDA-Approved or CE-Marked Tests with Epigenetic Component
Table 140: Global Market for Liquid Biopsy, by Analysis Platform, Through 2025
Table 141: Global Market for Liquid Biopsy, by Region, Through 2025
Table 142: Global Market for Liquid Biopsy in Cancer Applications, by Region, Through 2025
Table 143: Global Market for Liquid Biopsy for NIPT, by Region, Through 2025
Table 144: Global Market for Liquid Biopsy in Transplant Applications, by Region, Through 2025
Table 145: Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
Table 146: iPSCs Banks Worldwide, 2019
Table 147: Global Market for Induced Pluripotent Stem Cells, by Country/Region, Through 2026
Table 148: U.S. Market for Induced Pluripotent Stem Cells, by State, Through 2026
Table 149: European Market for Induced Pluripotent Stem Cells, by Country, Through 2026
Table 150: Asia-Pacific Market for Induced Pluripotent Stem Cells, by Country, Through 2026
Table 151: Global Market for the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, Through 2026
Table 152: Global Market for the Generation of Induced Pluripotent Stem Cells, by Method, Through 2026
Table 153: Global Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 154: U.S. Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 155: European Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 156: Asia-Pacific Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 157: Rest of the World Market for Induced Pluripotent Stem Cell Products, by Application, Through 2026
Table 158: Global Market for Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, Through 2026
Table 159: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Species, Through 2026
Table 160: Global Market for Induced Pluripotent Stem Cell-Derived Cells, by Application, Through 2026
Table 161: Global Market for Induced Pluripotent Stem Cell-Related Products, by Product Function, Through 2026
Table 162: Global Market for Induced Pluripotent Stem Cells in Research and Clinical Uses, Through 2026
Table 163: Major Commercial Suppliers of Induced Pluripotent Stem Cells Products, by Country
Table 164: Major Commercial Manufacturers of Induced Pluripotent Stem Cells, by Country
Table 165: Major Companies Providing iPSC Contract Services, by State/Country
Table 166: Global Market for Induced Pluripotent Stem Cell Contract Services, by Country/Region, Through 2026
Table 167: Global Market for Cell Therapy Biomanufacturing, by Product Type, Through 2025
Table 168: Global Market for Cell Therapy Biomanufacturing, by Application, Through 2025
LIST OF FIGURES
Figure 1: Global Market for Exosome Diagnostics and Therapeutics, by Application, 2019-2026
Figure 2: Publication Trends for Exosomes, 2010-2020
Figure 3: U.S. Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 4: European Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 5: Global Market Shares of Bioinformatics, by Application, 2019
Figure 6: Collaboration within the Bioinformatics Arena, by Country, Since 2016
Figure 7: Number of Drug Approvals, by FDA’s CDER, 2008-2020
Figure 8: Number of CDER’s Annual Novel Drug Approvals, 2009-2019
Figure 9: Global Market Shares of Sequencing Services and Platforms, 2019
Figure 10: Global Market Shares of Bioinformatics, by Solution, 2019
Figure 11: Global Market Shares of Bioinformatics, by End User, 2019
Figure 12: Global Market Shares of Bioinformatics, by Region, 2019
Figure 13: Phases in the Drug Discovery and Development Process
Figure 14: Application of Bioinformatics in Clinical Trials
Figure 15: Global Market for Cell and Gene Therapy, by Therapy Type, 2019-2026
Figure 16: Total Number of Clinical Trials, by Phase, 2020
Figure 17: Global Market for Clinical Next-Generation Sequencing, by Disease Class, 2019-2025
Figure 18: Global Market for Life Science Tools and Diagnostics, by Product Type, 2018-2025
Figure 19: Global Market Shares of Life Science Tools and Diagnostics, by Region, 2019
Figure 20: RoW Market for Life Science Tools and Diagnostics, 2018-2025
Figure 21: Global Market for DNA Sequencing, by Major Segment, 2020-2026
Figure 22: Global Market for mRNA Therapeutics, by Country/Region, 2020-2026
Figure 23: Global Market for mRNA Therapeutics, by Product Segment, 2020-2026
Figure 24: Global Market for mRNA Therapeutics, by Disease Type, 2020-2026
Figure 25: Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 26: Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
Figure 27: Incidence of Cancer, 2020
Figure 28: Mortality of Cancer, 2020
Figure 29: Major Issue in Stem Cell Research in Iran, 2017
Figure 30: Global Market Shares of Cancer Stem Cells, by Region, 2020
Figure 31: North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 32: European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 33: Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 34: RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 35: Global Market Shares for Research Antibodies, by Application, 2019
Figure 36: Global Market Shares for Research Antibodies, by Product, 2019
Figure 37: Global Market Shares for Research Antibodies, by Clonality, 2019
Figure 38: Global Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 39: Global Market Shares for Research Antibodies, by Host Species, 2019
Figure 40: Global Market Shares for Research Antibodies, by End User, 2019
Figure 41: Global Market Shares for Research Antibodies, by Region, 2019
Figure 42: Global Market Ranking of Research Antibodies, by Manufacturer, 2019
Figure 43: Global Market for Liquid Biopsy, by Disease Class, 2019-2025
Figure 44: Global Market for Induced Pluripotent Stem Cells, by Country/Region, 2020-2026
Figure 45: Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020
Figure 46: Global Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 47: U.S. Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 48: European Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 49: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 50: Rest of the World Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 51: Global Market Shares of Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2020
Figure 52: Global Market Shares of Induced Pluripotent Stem Cell-Derived Cells, by Application, 2020
Figure 53: Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
Figure 54: Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
Figure 55: Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
Figure 1: Global Market for Exosome Diagnostics and Therapeutics, by Application, 2019-2026
Figure 2: Publication Trends for Exosomes, 2010-2020
Figure 3: U.S. Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 4: European Patent Documents by Published, Filed and Granted Dates, 2015-2021
Figure 5: Global Market Shares of Bioinformatics, by Application, 2019
Figure 6: Collaboration within the Bioinformatics Arena, by Country, Since 2016
Figure 7: Number of Drug Approvals, by FDA’s CDER, 2008-2020
Figure 8: Number of CDER’s Annual Novel Drug Approvals, 2009-2019
Figure 9: Global Market Shares of Sequencing Services and Platforms, 2019
Figure 10: Global Market Shares of Bioinformatics, by Solution, 2019
Figure 11: Global Market Shares of Bioinformatics, by End User, 2019
Figure 12: Global Market Shares of Bioinformatics, by Region, 2019
Figure 13: Phases in the Drug Discovery and Development Process
Figure 14: Application of Bioinformatics in Clinical Trials
Figure 15: Global Market for Cell and Gene Therapy, by Therapy Type, 2019-2026
Figure 16: Total Number of Clinical Trials, by Phase, 2020
Figure 17: Global Market for Clinical Next-Generation Sequencing, by Disease Class, 2019-2025
Figure 18: Global Market for Life Science Tools and Diagnostics, by Product Type, 2018-2025
Figure 19: Global Market Shares of Life Science Tools and Diagnostics, by Region, 2019
Figure 20: RoW Market for Life Science Tools and Diagnostics, 2018-2025
Figure 21: Global Market for DNA Sequencing, by Major Segment, 2020-2026
Figure 22: Global Market for mRNA Therapeutics, by Country/Region, 2020-2026
Figure 23: Global Market for mRNA Therapeutics, by Product Segment, 2020-2026
Figure 24: Global Market for mRNA Therapeutics, by Disease Type, 2020-2026
Figure 25: Global Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 26: Total Cost per Capita of Cancer in Europe (Direct, Indirect and Informal Costs in Each Country), 2018
Figure 27: Incidence of Cancer, 2020
Figure 28: Mortality of Cancer, 2020
Figure 29: Major Issue in Stem Cell Research in Iran, 2017
Figure 30: Global Market Shares of Cancer Stem Cells, by Region, 2020
Figure 31: North American Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 32: European Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 33: Asia-Pacific Market Shares of Cancer Stem Cell, by Cancer Type, 2020
Figure 34: RoW Market Shares of Cancer Stem Cells, by Cancer Type, 2020
Figure 35: Global Market Shares for Research Antibodies, by Application, 2019
Figure 36: Global Market Shares for Research Antibodies, by Product, 2019
Figure 37: Global Market Shares for Research Antibodies, by Clonality, 2019
Figure 38: Global Market Shares for Research Antibodies, by Major Reactivities, 2019
Figure 39: Global Market Shares for Research Antibodies, by Host Species, 2019
Figure 40: Global Market Shares for Research Antibodies, by End User, 2019
Figure 41: Global Market Shares for Research Antibodies, by Region, 2019
Figure 42: Global Market Ranking of Research Antibodies, by Manufacturer, 2019
Figure 43: Global Market for Liquid Biopsy, by Disease Class, 2019-2025
Figure 44: Global Market for Induced Pluripotent Stem Cells, by Country/Region, 2020-2026
Figure 45: Global Market Shares of the Generation of Induced Pluripotent Stem Cells, by Reprogramming Method, 2020
Figure 46: Global Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 47: U.S. Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 48: European Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 49: Asia-Pacific Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 50: Rest of the World Market Shares of Induced Pluripotent Stem Cell Products, by Application, 2020
Figure 51: Global Market Shares of Induced Pluripotent Stem Cell-Derived Tissue Cells, by Type, 2020
Figure 52: Global Market Shares of Induced Pluripotent Stem Cell-Derived Cells, by Application, 2020
Figure 53: Global Market for Cell Therapy Biomanufacturing, by Product Type, 2019-2025
Figure 54: Global Market for Cell Therapy Biomanufacturing, by Region, 2019-2025
Figure 55: Global Market Share for Cell Therapy Biomanufacturing, by Region, 2025
